• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 28, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

ESMO emphasises importance of cancer on the global health agenda

Bioengineer by Bioengineer
May 24, 2018
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: © European Society for Medical Oncology

LUGANO, Switzerland, 24 May 2018 – At the 71st World Health Assembly (WHA) in Geneva, Switzerland, (1) ESMO, the leading professional organisation for medical oncology, delivered two statements positioning cancer as a priority on the World Health Organisation's (WHO) global agenda. Presenting its recommendations for action to the international community, ESMO advocated the strengthening of health systems to achieve Universal Health Coverage and to provide essential secondary healthcare services to the millions of cancer patients who die prematurely due to lack of access to appropriate treatment. In particular, ESMO called on the WHO to ensure that governments would be required to take specific actions in the interest of cancer control.

The widespread availability of secondary healthcare services to cancer patients – ESMO stressed at the WHA – depends on the presence of sufficient numbers of well-trained oncology professionals with sustainable access to the resources required to perform surgery, deliver radiotherapy, administer cancer treatments, and provide supportive and palliative care. ESMO is active in many of these areas and is able to support the individual efforts of Member States.

In a separate address, ESMO spoke out on the issue of shortages of medicines and reiterated its support to WHO initiatives in this field, including the Global Reporting System for monitoring the supply of essential cancer medicines. ESMO also voiced its agreement with the WHO's position that "investments in access to cancer medicines should be made where they offer the greatest value for money" and drew attention to the ESMO Magnitude of Clinical Benefit Scale (2), a tool designed to help health authorities prioritise the reimbursement of cancer medicines based on their potential to improve patient outcomes.

Dr Alexandru Eniu, Chair of the ESMO Global Policy Committee, underlined that, "ESMO has worked with the WHO for over 15 years to improve cancer care – not just in Europe, but worldwide. The platform we were given to talk about cancer at this year's WHA illustrates how prominent the topic is becoming on the global health agenda and confirms the relevance of our continued collaboration." ESMO congratulates the WHO as it celebrates its 70th anniversary and look forward to continuing the fruitful collaboration.

ESMO President Josep Tabernero added: "It was a privilege for us to be able to speak directly to the international community about the pressing global health issue that is cancer. ESMO is ready to support the WHO and its Member States in strengthening the medical oncology workforce and in identifying the most cost-effective interventions and treatments that can immediately help reduce the number of cancer deaths worldwide."

###

Notes to Editors

Watch the video "ESMO and WHO collaboration: 15 years together to improve cancer care": https://www.youtube.com/watch?v=Uu7MprOF2vc&feature=youtu.be

References

1 http://www.who.int/world-health-assembly/seventy-first The World Health Assembly is the decision-making body of the WHO and convenes annually to determine its policies based on a specific health agenda. As a non-State actor in official relations with the World Health Organisation, ESMO was invited to contribute to the WHA discussion in preparation of the third UN High-level Meeting of the General Assembly on the prevention and control of non-communicable diseases, to be held in September http://www.who.int/ncds/governance/third-un-meeting/en/

2 http://www.esmo.org/Policy/Magnitude-of-Clinical-Benefit-Scale

About the European Society for Medical Oncology (ESMO)

ESMO is the leading professional organisation for medical oncology. With 18,000 members representing oncology professionals from over 150 countries worldwide, ESMO is the society of reference for oncology education and information. We are committed to supporting our members to develop and advance in a fast-evolving professional environment. Visit http://www.esmo.org

Media Contact

ESMO Press Office
[email protected]
@myesmo

http://www.esmo.org

Original Source

http://esmo.org/Press-Office/Press-Releases/Cancer-Global-Health-Agenda-WHA

Share12Tweet7Share2ShareShareShare1

Related Posts

Rewrite Barriers and solutions for introducing donation after circulatory death (DCD) in Japan as a headline for a science magazine post, using no more than 8 words

August 28, 2025

Rewrite Organic-inorganic covalent selenium reversing ischemic reperfusion injury as a headline for a science magazine post, using no more than 8 words

August 28, 2025

Rewrite Nuclear PKM2: a signal receiver, a gene programmer, and a metabolic modulator as a headline for a science magazine post, using no more than 8 words

August 28, 2025

Boosting Graduate Seminar Engagement with Active Learning

August 28, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    149 shares
    Share 60 Tweet 37
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    82 shares
    Share 33 Tweet 21

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Rewrite Barriers and solutions for introducing donation after circulatory death (DCD) in Japan as a headline for a science magazine post, using no more than 8 words

Rewrite Insulin resistance in school-age children: comparison surrogate diagnostic markers as a headline for a science magazine post, using no more than 8 words

Rewrite Validation of the cancer fatigue scale (CFS) in a UK population as a headline for a science magazine post, using no more than 7 words

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.